Oncology

HR+ HER2- Breast Cancer

Expert Perspectives in HR+ HER2- Breast Cancer to Cover Key Topics in HR+ HER2- Breast Cancer Treatment

expert perspectives by Tom Iarocci, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. On behalf of Expert Perspectives in Medicine Editor-in-Chief Tom Iarocci, MD, we are delighted to introduce the community-selected topics for Expert Perspectives in HR+ HER2- Breast Cancer. We hope you will find these topics of value in your clinical practice.

VIEW THE TOPICS

Expert Roundtables

Advances in the Treatment of HR+/HER2- Breast Cancer
Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies
HR+/HER2- Breast Cancer: Approach to Metastatic Disease
Preserving Health-Related Quality of Life in Patients With Advanced Breast Cancer
The Role of Biomarkers in Treatment Selection for Patients With HR+ Metastatic Breast Cancer

Clinical Topic Updates

Biomarkers of Response in HR+/HER2- Breast Cancer
Conference Roundup: Locally Advanced HR+/HER2- Breast Cancer
The Importance of Next-Generation Sequencing in Guiding Therapy Selection
Mechanisms of Action of CDK4/6 Inhibition in Breast Cancer: Recent Insights
Second-line Treatment for Advanced/Metastatic HR+/HER2- Breast Cancer
The Role of Gene Expression Profiles in Breast Cancer Treatment

Patient Care Perspectives

Breast Cancer Immuno-Oncology and the Effects of Treatments on the Immune Milieu
Challenges in the Multidisciplinary Management of Breast Cancer
First-line Therapy for Advanced HR+/HER2- Breast Cancer
HR+/HER2- Breast Cancer: Approach to Progression During Aromatase Inhibitor Therapy
Novel Options for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Premenopausal Women With Advanced HR+ Breast Cancer